Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Menorrhagia × Progesterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Dysplasia 1 Menorrhagia 1 Leiomyoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Breast Neoplasms 1

Interventions

estradiol, norethindrone drug combination 2 elagolix 2 Norethindrone Acetate 2 Estradiol 2 vilaprisan 1 ulipristal 1 Progesterone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01441635 2021-07-13

Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

AbbVie

Phase 2 Completed

271 enrolled 38 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡